Respiratory syncytial virus outbreak defined by rapid screening in a neonatal intensive care unit

E A Dizdar1, C Aydemir, O Erdeve

  • 1Neonatal Intensive Care Unit, Zekai Tahir Burak Women's Health and Education Hospital, Hamamonu, Ankara, Turkey. drevrim@yahoo.com

Insights

This study details a large respiratory syncytial virus (RSV) outbreak in a neonatal intensive care unit (NICU). Early detection via rapid testing and palivizumab prophylaxis helped control the RSV spread in high-risk infants.

Area of Science:

  • Neonatal Medicine
  • Infectious Disease Epidemiology
  • Pediatric Pulmonology

Background:

  • Palivizumab is approved for preventing respiratory syncytial virus (RSV) in high-risk infants but not routinely recommended for NICU outbreaks.
  • Neonatal intensive care units (NICUs) are vulnerable to RSV outbreaks, posing significant risks to premature infants.

Purpose of the Study:

  • To report on the early detection and management of an RSV outbreak in a NICU setting.
  • To evaluate the effectiveness of rapid antigen testing and palivizumab prophylaxis in controlling RSV spread within a NICU.

Main Methods:

  • An RSV outbreak in a NICU was detected using a rapid antigen test (Respi-Strip((R))) during a screening trial.
  • Palivizumab prophylaxis was administered to 37 premature infants following initial RSV detections.
  • Infection control measures were implemented alongside palivizumab treatment.

Main Results:

  • Eleven preterm infants initially tested positive for RSV.
  • Two additional asymptomatic cases were identified through further screening.
  • Two symptomatic cases were detected post-palivizumab administration, indicating limited treatment efficacy in already infected infants.

Conclusions:

  • This represents a large RSV outbreak in a NICU identified early through rapid testing.
  • Infection control measures combined with palivizumab prophylaxis were effective in controlling the outbreak.
  • Early detection and intervention are crucial for managing RSV outbreaks in vulnerable neonatal populations.

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...